1.Urban JP., Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003. 5:120–30.
2.Freemont AJ., Watkins A., Le Maitre C., Jeziorska M., Hoyland JA. Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol. 2002. 196:374–9.
Article
3.Hoppenfeld S. Percutaneous removal of herniated lumbar discs. 50 cases with ten-year follow-up periods. Clin Orthop Relat Res. 1989. 238:92–7.
4.Yeung AT., Tsou PM. Posterolateral endoscopic excision for lumbar disc herniation: Surgical technique, outcome, and complications in 307 consecutive cases. Spine. 2002. 27:722–31.
5.White AH., von Rogov P., Zucherman J., Heiden D.Lumbar laminectomy for herniated disc: a prospective controlled comparison with internal fixation fusion. Spine. 1987. 12:305–7.
6.Eie N. Comparison of the results in patients operated upon for ruptured lumbar discs with and without spinal fusion. Acta Neurochir. 1978. 41:107–13.
Article
7.Eie N., Solgaard T., Kleppe H. The knee-elbow position in lumbar disc surgery: a review of complications. Spine. 1983. 8:897–900.
Article
8.Freeman BJ., Davenport J. Total disc replacement in the lumbar spine: a systematic review of the literature. Eur Spine J. 2006. 15:439–47.
Article
9.An HS., Thonar EJ., Masuda K. Biological repair of intervertebral disc. Spine. 2003. 28:86–92.
Article
10.Ganey TM., Meisel HJ. A potential role for cell-based therapeutics in the treatment of intervertebral disc herniation. Eur Spine J. 2002. 11:206–14.
Article
11.Gan JC., Ducheyne P., Vresilovic EJ., Swaim W., Shapiro IM. Intervertebral disc tissue engineering I: characterization of the nucleus pulposus. Clin Orthop Relat Res. 2003. 411:305–14.
Article
12.Yoon ST. Molecular therapy of the intervertebral disc. Spine J. 2005. 5:280–6.
Article
13.Baums MH., Heidrich G., Schultz W., Steckel H., Kahl E., Klinger HM. Autologous chondrocyte transplantation for treating cartilage defects of the talus. J Bone Joint Surg Am. 2006. 88:303–8.
Article
14.Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994. 331:889–95.
Article
15.Benya PD., Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 1982. 30:215–24.
Article
16.Lemare F., Steimberg N., Le Griel C., Demignot S., Adolphe M. Dedifferentiated chondrocytes cultured in alginate beads: restoration of the differentiated phenotype and of the metabolic responses to interleukin-1beta. J Cell Physiol. 1998. 176:303–13.
17.Bayliss MT., Johnstone B., ODBrien JP. 1988 Volvo award in basic science. Proteoglycan synthesis in the human intervertebral disc. Variation with age, region and pathology. Spine. 1988. 13:972–81.
18.Chou AI., Bansal A., Miller GJ., Nicoll SB. The effect of serial monolayer passaging on the collagen expression profile of outer and inner anulus fibrosus cells. Spine. 2006. 31:1875–81.
Article
19.Kluba T., Niemeyer T., Gaissmaier C., Grunder T. Human anulus fibrosus and nucleus pulposus cells of the intervertebral disc: effect of degeneration and culture system on cell phenotype. Spine. 2005. 30:2743–48.
20.Wang JY., Baer AE., Kraus VB., Setton LA. Intervertebral disc cells exhibit differences in gene expression in alginate and monolayer culture. Spine. 2001. 26:1747–51.
Article
21.Tullberg-Reinert H., Jundt G. In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem Cell Biol. 1999. 112:271–6.
22.Farndale RW., Buttle DJ., Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986. 883:173–7.
Article
23.Loeser RF., Sadiev S., Tan L., Goldring MB. Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for alpha1beta1 and alpha2beta1 integrins in mediating chondrocyte adhesion to types II and VI collagen. Osteoarthritis Cartilage. 2000. 8:96–105.
24.Wang H., Kandel RA. Chondrocytes attach to hyaline or calcified cartilage and bone. Osteoarthritis Cartilage. 2004. 12:56–64.
25.Hong Y., Gao C., Xie Y., Gong Y., Shen J. Collagen-coated polylactide microspheres as chondrocyte microcarriers. Biomaterials. 2005. 26:6305–13.
Article
26.Yashiki S., Umegaki R., Kino-Oka M., Taya M. Evaluation of attachment and growth of anchorage-dependent cells on culture surfaces with type I collagen coating. J Biosci Bioeng. 2001. 92:385–8.
Article
27.Eyre DR., Muir H. Quantitative analysis of types I and II collagens in human intervertebral discs at various ages. Biochim Biophys Acta. 1977. 492:29–42.
Article
28.Johnstone B., Bayliss MT. The large proteoglycans of the human intervertebral disc. Changes in their biosynthesis and structure with age, topography, and pathology. Spine. 1995. 20:674–84.
29.Lee JY., Hall R., Pelinkovic D, et al. New use of a three-dimensional pellet culture system for human intervertebral disc cells: initial characterization and potential use for tissue engineering. Spine. 2001. 26:2316–22.
30.Sato M., Asazuma T., Ishihara M, et al. An atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) for the culture of annulus fibrosus cells from an intervertebral disc. J Biomed Mater Res A. 2003. 64:248–56.
Article